Related references
Note: Only part of the references are listed.The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells
Yipu Lin et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Lisa M. Dunkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers
Vivian K. Y. Leung et al.
VACCINE (2017)
Immune history and influenza virus susceptibility
Sarah Cobey et al.
CURRENT OPINION IN VIROLOGY (2017)
Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
Brendan Flannery et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time
Kuan-Ying A. Huang et al.
SCIENTIFIC REPORTS (2017)
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season
Danuta M. Skowronski et al.
CLINICAL INFECTIOUS DISEASES (2016)
2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
Richard K. Zimmerman et al.
CLINICAL INFECTIOUS DISEASES (2016)
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015
Brendan Flannery et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Edward A. Belongia et al.
LANCET INFECTIOUS DISEASES (2016)
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
Katelyn M. Gostic et al.
SCIENCE (2016)
Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11
Mark G. Thompson et al.
VACCINE (2016)
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Carole J. Henry Dunand et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season
Benjamin S. Chambers et al.
CELL REPORTS (2015)
Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
Huong Q. McLean et al.
CLINICAL INFECTIOUS DISEASES (2014)
Low 2012-13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
Danuta M. Skowronski et al.
PLOS ONE (2014)
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season
Susanne L. Linderman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Influenza Vaccine Effectiveness in the Community and the Household
Suzanne E. Ohmit et al.
CLINICAL INFECTIOUS DISEASES (2013)
Immune history shapes specificity of pandemic H1N1 influenza antibody responses
Yang Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms
Yanming An et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Single Hemagglutinin Mutations That Alter both Antigenicity and Receptor Binding Avidity Influence Influenza Virus Antigenic Clustering
Yang Li et al.
JOURNAL OF VIROLOGY (2013)
Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
Bjorn F. Koel et al.
SCIENCE (2013)
Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
Rafael A. Medina et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
Gui-Mei Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy
Suman R. Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Viva la revolucion: rethinking influenza A virus antigenic drift
Jonathan W. Yewdell
CURRENT OPINION IN VIROLOGY (2011)
Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design
Chih-Jen Wei et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response
Zhongying Chen et al.
VACCINE (2010)
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift
Scott E. Hensley et al.
SCIENCE (2009)
Influenza vaccine: The challenge of antigenic drift
F. Carrat et al.
VACCINE (2007)
Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin
Y Abe et al.
JOURNAL OF VIROLOGY (2004)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Share Paper
